Moorestown, NJ, August 7, 2020 — Tabula Rasa HealthCare ®(TRHC) (NASDAQ: TRHC) a healthcare technology company advancing the field of medication safety, has obtained full accreditation by the American Society of Health Systems Pharmacists (ASHP) Commission on Credentialing for eight years for its Post Graduate Year 1 (PGY1) residency. TRHC’s program provides residents with several rotation experiences, including total quality management, pharmaco-informatics, research, and scientific publication writing.
TRHC’s residency program consists of exposure to the Program of All-inclusive Care for the Elderly (PACE) Call Center, allowing residents to play a pivotal role as members of interdisciplinary healthcare teams with the ability to impact patient care through various telepharmacy methods. The program also offers residents the opportunity to experience Enhanced Medication Therapy Management (EMTM) and clinical pharmacogenomics services, which are not available in most residency programs.
“The dexterity with leadership, management, and collaboration at Tabula Rasa HealthCare truly supports the foundation for this residency program and fosters pharmacists’ growth early in their career,” TRHC Chairman and CEO, Calvin H. Knowlton, PhD said. “ASHP accreditation status ensures TRHC’s residency program follows the same quality standards as traditional pharmacy roles in a non-traditional setting.”
A differentiation of TRHC’s program allows residents to experience their time in a business centered-pharmacy setting. Residents attain skills from the TRHC curriculum that enable them to practice in a wide range of pharmacy services and helps to develop new/emerging opportunities for pharmacists.
“Every resident at TRHC works closely with TRHC’s leadership team providing a unique opportunity to learn management skills and their clinical practice,” states TRHC Director, Pharmacy Practice Residency Programs, Nishita Shan Amin, PharmD. “Additionally, residents actively participate in educational programs, including lectures and publications, provided to TRHC’s more than 700 pharmacists regarding new information optimizing drug therapy.”
“The TRHC residency experience is a rare opportunity to gain a clinical perspective in an environment that focuses on medication safety and patient outcome,” said former PGY1 Resident Anna Furman. “The training is innovative and forward-thinking with supportive preceptors and passionate colleagues. I have progressed more than I ever imagined I could in just one year. TRHC has allowed me to see the profession of pharmacy and geriatric healthcare in a completely new light.”
About Tabula Rasa HealthCare
TRHC is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize performance to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Medication risk management is TRHC’s lead offering, and its cloud-based software applications provide solutions for a range of payers, providers and other healthcare organizations. For more information, visit TRHC.com.
This press release includes forward-looking statements that we believe to be reasonable as of today’s date, including statements regarding Medication Risk Mitigation technology. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the SEC on March 2, 2020, and in subsequent reports filed with or furnished to the SEC, copies of which are available free of charge within the Investor Relations section of the TRHC website ir.trhc.com or upon request from our Investor Relations Department. Any forward-looking statement speaks only as of the date on which it was made. TRHC assumes no obligation and does not intend to update these forward-looking statements, except as required by law, to reflect events or circumstances occurring after today’s date.
TRHC Media Contact
T: (215) 870-0829
T: (856) 912-5714
TRHC Investor Contact
T: (866) 648-2767